In vivo data of reduced S100A4 expression in colon cancer of other studies were mainly obtained by inhibiting the hyperactivated Wnt/β-catenin pathway and therefore indirectly reducing the S100A4 transcription [5],[17],[19],[20]. The gene discussed is S100A4; the disease is malignant colon neoplasm.